[08/25/20]
Posted on August 25, 2020 in Health Law News
Published by: Hall Render
Mergers and acquisitions in the health care industry present unique challenges that are not often present when undertaking similar transactions in other industries. Because of health care’s highly regulated nature, parties may falter if a health care transaction is not reviewed and negotiated carefully with respect to the distinct concerns that health care presents.... READ MORE
Tags: Arbitration Clauses, attorney-client privilege, Confidential Information, Due Diligence, Health Care M&A Series, MA, Mergers and Acquisitions
[07/28/20]
Posted on July 28, 2020 in Health Law News
Published by: Hall Render
Mergers and acquisitions in the health care industry present unique challenges that are not often present when undertaking similar transactions in other industries. Because of health care’s highly regulated nature, parties may falter if a health care transaction is not reviewed and negotiated carefully with respect to the distinct concerns that health care presents. ... READ MORE
Tags: Antitrust, Competitive Behavior, Department of Justice, DOJ, Federal Trade Commission, FTC, Hart-Scott Rodino Act, Health Care M&A Series, Mergers and Acquisitions
[05/26/20]
Posted on May 26, 2020 in COVID-19 Daily Updates, Health Law News
Published by: Hall Render
The events caused by COVID-19 and the pandemic’s ripple effects has certainly caused pause and required a renewed approach to most of life’s activities. Shockingly, legal due diligence conducted in a health care M&A transaction is not immune from such pause and reassessment. New considerations of novel or previously dormant factors will be required... READ MORE
Tags: 1135 Waivers, CARES Act, COVID-19, Due Diligence, Health Care M&A, Mergers and Acquisitions, Payment Protection Program, PPP, Stark blanket waivers
